Skip to content
Search

Latest Stories

melanie saville

After COVID vaccines, time to use mRNA tech against other infectious diseases
Science & Tech

After COVID vaccines, time to use mRNA tech against other infectious diseases

Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough. But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.

Can the world learn lessons from vaccine inequity?
GZERO Live

Can the world learn lessons from vaccine inequity?

GZERO Media and the Bill & Melinda Gates Foundation convened leading experts in public health, research, development, and philanthropy on Thursday to discuss the uneven state of global recovery from health and economic perspectives.

Missed Shot: Whatever happened to equitable distribution? Wednesday, March 2, 2022 | 11:00 am ET / 8:00 am PT
Events

Whatever happened to equitable distribution? Live townhall today at 11 am ET

Today at 11 am ET, GZERO Media and the Bill & Melinda Gates Foundation will convene leading experts in public health, research, development, and philanthropy to discuss the uneven state of recovery from health and economic perspectives.As the world marks the two-year anniversary of the COVID-19 pandemic, most regions are still in the throes of outbreaks, and global vaccination rates are inconsistent – high in high-income countries, low in low-income countries.